PPAC_HUMAN - dbPTM
PPAC_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PPAC_HUMAN
UniProt AC P24666
Protein Name Low molecular weight phosphotyrosine protein phosphatase
Gene Name ACP1
Organism Homo sapiens (Human).
Sequence Length 158
Subcellular Localization Cytoplasm.
Protein Description Acts on tyrosine phosphorylated proteins, low-MW aryl phosphates and natural and synthetic acyl phosphates. Isoform 3 does not possess phosphatase activity..
Protein Sequence MAEQATKSVLFVCLGNICRSPIAEAVFRKLVTDQNISENWRVDSAATSGYEIGNPPDYRGQSCMKRHGIPMSHVARQITKEDFATFDYILCMDESNLRDLNRKSNQVKTCKAKIELLGSYDPQKQLIIEDPYYGNDSDFETVYQQCVRCCRAFLEKAH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAEQATKSV
------CHHHHHHHH
20.011587862
7Ubiquitination-MAEQATKSVLFVCL
-CHHHHHHHHHHHHC
41.40-
7Ubiquitination-MAEQATKSVLFVCL
-CHHHHHHHHHHHHC
41.40-
8PhosphorylationMAEQATKSVLFVCLG
CHHHHHHHHHHHHCC
21.5063715447
13S-palmitoylationTKSVLFVCLGNICRS
HHHHHHHHCCHHCCC
2.9329575903
18S-palmitoylationFVCLGNICRSPIAEA
HHHCCHHCCCHHHHH
4.0129575903
20PhosphorylationCLGNICRSPIAEAVF
HCCHHCCCHHHHHHH
19.0821815630
29UbiquitinationIAEAVFRKLVTDQNI
HHHHHHHHHHCCCCC
35.53-
29UbiquitinationIAEAVFRKLVTDQNI
HHHHHHHHHHCCCCC
35.53-
32PhosphorylationAVFRKLVTDQNISEN
HHHHHHHCCCCCCCC
42.1620068231
37PhosphorylationLVTDQNISENWRVDS
HHCCCCCCCCCCCCC
32.2120068231
44 (in isoform 2)Phosphorylation-19.5628348404
44PhosphorylationSENWRVDSAATSGYE
CCCCCCCCCCCCCCC
19.5628796482
47PhosphorylationWRVDSAATSGYEIGN
CCCCCCCCCCCCCCC
23.5428796482
48PhosphorylationRVDSAATSGYEIGNP
CCCCCCCCCCCCCCC
34.3528796482
48 (in isoform 2)Phosphorylation-34.3528348404
50PhosphorylationDSAATSGYEIGNPPD
CCCCCCCCCCCCCCC
12.2528796482
55 (in isoform 2)Phosphorylation-20.2328348404
58PhosphorylationEIGNPPDYRGQSCMK
CCCCCCCCCCCHHHH
23.5528796482
62PhosphorylationPPDYRGQSCMKRHGI
CCCCCCCHHHHHHCC
21.0021652233
62 (in isoform 2)Phosphorylation-21.0024719451
66MethylationRGQSCMKRHGIPMSH
CCCHHHHHHCCCHHH
13.33-
79 (in isoform 3)Ubiquitination-21.7521890473
79PhosphorylationSHVARQITKEDFATF
HHHHHHCCHHHHCCC
21.75116521
80UbiquitinationHVARQITKEDFATFD
HHHHHCCHHHHCCCC
57.84-
85PhosphorylationITKEDFATFDYILCM
CCHHHHCCCCEEEEE
19.6246157949
88NitrationEDFATFDYILCMDES
HHHCCCCEEEEECHH
7.50-
88PhosphorylationEDFATFDYILCMDES
HHHCCCCEEEEECHH
7.5028796482
92SulfoxidationTFDYILCMDESNLRD
CCCEEEEECHHHHHH
6.0130846556
109PhosphorylationRKSNQVKTCKAKIEL
HHCHHHHHHHHHHHH
22.0030576142
113SumoylationQVKTCKAKIELLGSY
HHHHHHHHHHHHCCC
23.39-
113 (in isoform 2)Ubiquitination-23.3921890473
113 (in isoform 1)Ubiquitination-23.3921890473
113AcetylationQVKTCKAKIELLGSY
HHHHHHHHHHHHCCC
23.3926051181
1132-HydroxyisobutyrylationQVKTCKAKIELLGSY
HHHHHHHHHHHHCCC
23.39-
113UbiquitinationQVKTCKAKIELLGSY
HHHHHHHHHHHHCCC
23.3921890473
113SumoylationQVKTCKAKIELLGSY
HHHHHHHHHHHHCCC
23.39-
119PhosphorylationAKIELLGSYDPQKQL
HHHHHHCCCCCCCCE
26.7430576142
120PhosphorylationKIELLGSYDPQKQLI
HHHHHCCCCCCCCEE
29.8230460777
124UbiquitinationLGSYDPQKQLIIEDP
HCCCCCCCCEEEECC
53.08-
132PhosphorylationQLIIEDPYYGNDSDF
CEEEECCCCCCCCCH
36.0119605366
133PhosphorylationLIIEDPYYGNDSDFE
EEEECCCCCCCCCHH
18.1619605366
137PhosphorylationDPYYGNDSDFETVYQ
CCCCCCCCCHHHHHH
48.4728464451
141PhosphorylationGNDSDFETVYQQCVR
CCCCCHHHHHHHHHH
25.2228796482
143PhosphorylationDSDFETVYQQCVRCC
CCCHHHHHHHHHHHH
10.5754129
156UbiquitinationCCRAFLEKAH-----
HHHHHHHHHC-----
54.6419608861
156AcetylationCCRAFLEKAH-----
HHHHHHHHHC-----
54.6419608861

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
132YPhosphorylationKinaseLCKP06239
PSP
133YPhosphorylationKinaseLCKP06239
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PPAC_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PPAC_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SMBT1_HUMANSFMBT1physical
16189514
RM20_HUMANMRPL20physical
16169070
FBP1L_HUMANFNBP1Lphysical
16169070
EPHA2_HUMANEPHA2physical
12167657
RL12_HUMANRPL12physical
22939629
ABRAL_HUMANABRACLphysical
26344197
PCBP1_HUMANPCBP1physical
26344197
PIPNA_HUMANPITPNAphysical
26344197
PPIL3_HUMANPPIL3physical
26344197
TALDO_HUMANTALDO1physical
26344197
ZBT43_HUMANZBTB43physical
27432908
PPAC_HUMANACP1physical
27432908
DJC13_HUMANDNAJC13physical
27432908
G45IP_HUMANGADD45GIP1physical
27432908
POTEE_HUMANPOTEEphysical
28514442
ACTBL_HUMANACTBL2physical
28514442
ACTB_HUMANACTBphysical
28514442
INSR_HUMANINSRphysical
9299573

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00173Adenine
Regulatory Network of PPAC_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Human red cell acid phosphatase (ACP1). The amino acid sequence ofthe two isozymes Bf and Bs encoded by the ACP1*B allele.";
Dissing J., Johnsen A.H., Sensabaugh G.F.;
J. Biol. Chem. 266:20619-20625(1991).
Cited for: PROTEIN SEQUENCE (ALLELE B; ISOFORMS 1 AND 2).
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-156, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-132, AND MASSSPECTROMETRY.
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules.";
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.;
Mol. Cell. Proteomics 4:1240-1250(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-132, AND MASSSPECTROMETRY.
"Regulation of the low molecular weight phosphotyrosine phosphatase byphosphorylation at tyrosines 131 and 132.";
Tailor P., Gilman J., Williams S., Couture C., Mustelin T.;
J. Biol. Chem. 272:5371-5374(1997).
Cited for: NUCLEOTIDE SEQUENCE (ISOFORM 2), TISSUE SPECIFICITY, PHOSPHORYLATIONAT TYR-132 AND TYR-133, AND MUTAGENESIS OF CYS-13; TYR-132 ANDTYR-133.

TOP